Lemanske RF, Mauger DT, Sorkness CA, et al, for the Childhood Asthma Research and Education (CARE) Network of the National, Heart, Lung, and Blood Institute. This study evaluated whether any of 3 ...

Please provide your email address to receive an email when new articles are posted on . Single-inhaler fluticasone furoate/umeclidinium/vilanterol triple therapy ...

Please provide your email address to receive an email when new articles are posted on . Global Initiative for Asthma (GINA) guidelines recommend single maintenance and reliever therapy (SMART) for ...

For patients with uncontrolled asthma despite the use of inhaled corticosteroids (ICS), common treatment options include addition of a long-acting beta agonist (LABA) and/or increasing the dose of ICS ...

Asthma remains one of the most prevalent chronic diseases in the US. 3 Although poor adherence substantially contributes to inadequate outcomes, even patients with high adherence often experience ...

Although epidemiologic studies involving U.S. patients with asthma show a greater burden in black patients than in whites, treatment recommendations are based on trials with few black participants.

Asthma is a chronic inflammatory condition marked by an imbalance in the immune response within the airways. According to Lancet, asthma affects around 339 million people globally. While conventional ...

Only 15% of patients were adherent to ICS therapy 3 months after their asthma exacerbation, and less that one-fourth of those remained adherent 9 months later. Improved adherence to inhaled ...

Objective Anxiety affects up to one-third of adults with asthma and is linked to poorer disease outcomes and reduced quality ...

SaveHealth reports seven asthma medication categories, including inhaled corticosteroids and biologics, helping manage ...

Chinese scientists have developed a groundbreaking cell therapy that could provide long-term relief for asthma patients with just a single shot. This new treatment, which has shown promising results ...